IL17A and type 2 diabetes mellitus: Studies in rodents have shown that after MERS-CoV infection, T2D mice presented immunoinflammatory abnormalities and developed an altered profile of cytokines, with increased expression of IL-17α following infection, observing that the presence of both T2D and the viral infection resulted in more deleterious lung damage and a dysregulated immune response [21].